What Menapharm Consulting does

Menapharm Consulting is a pharmaceutical market-entry and operations consulting firm that helps drug companies establish and run commercial presence across the Middle East and Africa. The company delivers four integrated services: Business Analysis (compliance checks, market research, SWOT, regulatory strategy, 5-year business plans), Regulatory Support (registration requirements, dossier compilation, submissions, variations, renewals), Distributor Management (selection, contract negotiation, inventory, sales reporting), and Marketing & Promotion (brand management, training materials, medical rep recruitment and management, forecasting and budgeting). Together these services function as a de facto regional office for clients that want MEA exposure without bearing the overhead of setting one up themselves.

The business model is professional-services based: engagements are quote-based with a shared-risk pricing structure, targeted exclusively at enterprise pharmaceutical clients. Go-to-market is relationship-driven and event-led, anchored on appearances at CPhI Worldwide (Milan, October 2026), WHX Dubai (January 2027) and Arab Health, supplemented by direct outreach via the company website. Disclosed clients include Leader Pharma (US), MAR-FARMA SRL (Italy, engaged since 2016) and TECNIMEDE GROUP (Portugal). The firm operates with nine employees from a Maltese headquarters (Lija) and a regional office in Abu Dhabi, with additional presence in the United Kingdom.

Following a recent merger with CPC Limited, Menapharm is now legally registered as CPC Limited in Malta while continuing to operate under the Menapharm brand. The company maintains a network of strategic partners and vetted distributors across MEA markets, which collectively represent a potential market access of approximately 850 million people. The MEA pharmaceuticals market is projected to grow from USD 30.1 billion in 2024 to USD 42.4 billion by 2030 at a 6.1% CAGR, providing the underlying tailwind for Menapharm's niche offering.

Name

Menapharm Consulting

Legal name

CPC Limited

Website

https://menapharm.eu

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Menapharm Consulting is a Malta-based pharmaceutical consulting firm that helps drug companies enter and operate in Middle East and African markets through four integrated services: business analysis, regulatory support, distributor management, and marketing and promotion.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Consulting

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Instrumentation, Controls & Automation Engineering Consulting (BPAHAIAM)

Keywords

• Pharmaceutical consulting services
• Market entry consulting
• Regulatory affairs consulting
• Pharmaceutical distributor management
• Middle East Africa consulting

Headquarters

HQ city

Lija

HQ country

Malta

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Consulting Services: Menapharm generates revenue through a range of consulting and advisory services including business analysis, regulatory support, distributor management, and marketing & promotion services. These are professional services billed to pharmaceutical companies seeking market entry in the Middle East and Africa.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Menapharm Consulting provides pharmaceutical manufacturers with market entry and operational support services in the Middle East and African (MEA) markets. The firm offers business analysis, regulatory support, distributor management, and marketing & promotion services designed to help pharmaceutical companies establish or expand their presence in the MEA region without the overhead of setting up their own local offices.

Product overview

Menapharm Consulting offers a unified portfolio of four integrated consulting services for pharmaceutical companies seeking to enter Middle East and African markets. The core offering comprises Business Analysis (compliance checks, market research, and strategic planning), Regulatory Support (registration, dossier compilation, and compliance), Distributor Management (selection, negotiation, and ongoing management), and Marketing & Promotion (brand management, medical rep training, and sales support). These services function as a coordinated suite, providing the full scope of support equivalent to a regional office without the overhead costs, with a shared-risk business model designed to reduce market entry risk while enabling fast and efficient market penetration.

Differentiator

Problem solved

Functional benefit

Products and services

• Business Analysis Market and business analysis service for pharmaceutical companies assessing entry or expansion into the Middle East and African markets. Delivered to pharmaceutical manufacturers seeking data-driven entry strategies.
• Regulatory Support Regulatory affairs consulting service that helps pharmaceutical manufacturers navigate product registration, licensing, and compliance requirements across MEA jurisdictions.
• Distributor Management Service that identifies, vets, and manages pharmaceutical distributors across Middle East and African markets on behalf of pharmaceutical manufacturers seeking local commercial partners.
• Marketing & Promotion Marketing and product promotion services supporting pharmaceutical launches and ongoing brand activities across the Middle East and African markets.

Quantifiable outcome

• Speed to market as the key competitive advantage

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• CPC LimitedcoreStrategic or Co-development PartnerMenapharm has merged with CPC Limited and will be registered as CPC Limited in Malta. They continue to operate under the Menapharm brand, which is widely recognized as a leading service provider to the pharma industry in the Middle East markets. This merger strengthens their operational infrastructure while maintaining their brand identity.
• Leader Pharma (US)minorStrategic or Co-development PartnerCustomer testimonial partner. Dev Kumar, CCO, provided testimonial praising Menapharm's expertise in helping establish pharmaceutical presence in MENA markets.
• MAR-FARMA SRL (Italy)minorStrategic or Co-development PartnerCustomer testimonial partner. Roberto Ricatti, CEO, has been working with Menapharm since 2016 to develop business in MENA and African regions.
• TECNIMEDE GROUP (Portugal)minorStrategic or Co-development PartnerCustomer testimonial partner. Bruno Alves, Business Development Manager, describes Menapharm as a key partner for pharma companies entering MENA markets with long-term regional experience.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• IQVIA: IQVIA is the world's largest life sciences data, technology, and consulting services provider. While far larger than Menapharm, its pharma market-entry and commercialization advisory practice competes for the same enterprise pharma clients.
• Certara: Certara is a larger, established life sciences consulting and regulatory science platform serving global pharma and biotech clients. It operates in the same regulatory and market-entry advisory space as Menapharm but at significantly greater scale and with proprietary technology.
• Parexel International: Parexel is one of the largest global CROs with deep regulatory, clinical, and market-access consulting capabilities for pharma. It is a broader incumbent that overlaps with Menapharm's regulatory and market-entry service lines but at much greater scale.

Direct peers

• ELC Group: ELC Group provides pharmaceutical regulatory affairs and compliance consulting services globally. It operates in the same professional-services regulatory niche as Menapharm, serving pharma clients seeking market authorization support.
• ProPharma Group: ProPharma Group provides regulatory compliance, consulting, and quality assurance services to pharmaceutical and biotech companies. It mirrors Menapharm's professional-services model of helping pharma clients navigate complex regulatory environments.
• PharmaLex: PharmaLex is a specialized pharmaceutical regulatory affairs, compliance, and consulting services provider. It is directly comparable to Menapharm's regulatory support service line and shares the model of providing outsourced pharma expertise to companies entering new markets.
• Arriello: Arriello provides regulatory affairs, pharmacovigilance, and market-entry consulting to pharma companies expanding internationally, including in emerging markets. Its service model and target customer base align closely with Menapharm's offering.
• PharmaVentures: PharmaVentures is a specialist pharma business development and licensing advisory firm. It is comparable to Menapharm in serving pharma clients with strategic market-entry, out-licensing, and partnership support — though without MENA regional specialization.

Regional players

• Acino International: Acino is a pharmaceutical company headquartered in Switzerland with a strong commercial presence across the Middle East and Africa. It is comparable to Menapharm's customer base rather than its service model — sharing the MENA-focused pharma distribution footprint that Menapharm supports.

Others

• Informa Pharma Intelligence: Informa Pharma Intelligence provides market intelligence, events, and consulting-adjacent services to the pharma industry, including the CPhI events Menapharm attends. It is an adjacent ecosystem player that influences the same client network rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/menapharm-consulting

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Menapharm Consulting